Literature DB >> 35173831

Role of ferroptosis-related molecular patterns in hepatocellular carcinoma microenvironment.

Jukun Wang1, Yu Li1, Chao Zhang1, Xin Chen1, Linzhong Zhu1, Tao Luo1.   

Abstract

Heterogeneity and complexity of hepatocellular carcinoma (HCC) have been an impediment to effective diagnosis and treatment of HCC. Mounting evidence suggests that ferroptosis-related genes (FRGs) regulate the development of HCC by affecting the tumor microenvironment (TME). Herein, we explored the role of ferroptosis-related molecular patterns in the HCC microenvironment. The transcriptome and corresponding clinicopathological data of HCC patients were downloaded from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database, respectively. Molecular patterns of ferroptosis were explored using consensus clustering analysis and ferroptosis-related molecular patterns in the individual patients were analyzed using principal component analysis (PCA). The ability of ferroptosis-related patterns to predict the biological status and survival outcomes of HCC patients was investigated. Based on the expression of FRGs, three molecular patterns related to ferroptosis were identified. Single sample gene set enrichment analysis (ssGSEA) showed that the molecular patterns associated with the worst prognosis were significantly correlated with high infiltration of immunosuppressive cells in the TME. Besides, we identified three ferroptosis gene clusters underlying the different biological features of the three ferroptosis patterns. Patients in the high-risk group had a worse biological status and survival outcomes than those in the low-risk group. This study demonstrates that ferroptosis-related molecular patterns lead to high heterogeneity in HCC. These molecular patterns can be used to assess the survival of HCC patients and guide the design of immunotherapy strategies for HCC patients. AJTR
Copyright © 2022.

Entities:  

Keywords:  Hepatocellular carcinoma; TCGA; ferroptosis; prognosis

Year:  2022        PMID: 35173831      PMCID: PMC8829608     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  34 in total

Review 1.  Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Matrix Biol       Date:  2015-04-22       Impact factor: 11.583

2.  Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.

Authors:  Shao-Lai Zhou; Zheng-Jun Zhou; Zhi-Qiang Hu; Xiao-Wu Huang; Zheng Wang; Er-Bao Chen; Jia Fan; Ya Cao; Zhi Dai; Jian Zhou
Journal:  Gastroenterology       Date:  2016-02-26       Impact factor: 22.682

Review 3.  The development of the concept of ferroptosis.

Authors:  Tal Hirschhorn; Brent R Stockwell
Journal:  Free Radic Biol Med       Date:  2018-09-28       Impact factor: 7.376

4.  Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma.

Authors:  Yaping Xu; Fei Fang; Hui Jiao; Xiaohui Zheng; Liyue Huang; Xue Yi; Wenxiu Zhao
Journal:  Cancer Immunol Immunother       Date:  2019-10-23       Impact factor: 6.968

Review 5.  Emerging Strategies of Cancer Therapy Based on Ferroptosis.

Authors:  Zheyu Shen; Jibin Song; Bryant C Yung; Zijian Zhou; Aiguo Wu; Xiaoyuan Chen
Journal:  Adv Mater       Date:  2018-01-22       Impact factor: 30.849

6.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

7.  Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.

Authors:  Christophe Louandre; Zakaria Ezzoukhry; Corinne Godin; Jean-Claude Barbare; Jean-Claude Mazière; Bruno Chauffert; Antoine Galmiche
Journal:  Int J Cancer       Date:  2013-04-08       Impact factor: 7.396

8.  Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

Authors:  Bastian Hoechst; Torsten Voigtlaender; Lars Ormandy; Jaba Gamrekelashvili; Fei Zhao; Heiner Wedemeyer; Frank Lehner; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

9.  Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis.

Authors:  Sunjae Lee; Adil Mardinoglu; Cheng Zhang; Doheon Lee; Jens Nielsen
Journal:  Nucleic Acids Res       Date:  2016-05-23       Impact factor: 16.971

Review 10.  Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.

Authors:  Chen Lu; Dawei Rong; Betty Zhang; Wubin Zheng; Xuehao Wang; Ziyi Chen; Weiwei Tang
Journal:  Mol Cancer       Date:  2019-08-29       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.